Abstract
Objectives: Fibroblast growth factor (FGF)-23 is a key regulator of mineral metabolism and has been linked with left ventricular hypertrophy in animal models. Most existing epidemiologic studies evaluated a C-terminal FGF23 assay which measures both the intact (active) hormone and inactive fragments. The relationship of intact FGF23 with cause-specific mortality is unknown. Design: Prospective analyses of data from Health, Aging, & Body Composition (HABC) study. Setting: Community-living adults aged 70 to 79 years with longitudinal follow up.
Original language | English (US) |
---|---|
Pages (from-to) | 711-717 |
Number of pages | 7 |
Journal | Journal of the American Geriatrics Society |
Volume | 69 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2021 |
Externally published | Yes |
Keywords
- FGF23
- assays
- cause-specific
- mortality
ASJC Scopus subject areas
- Geriatrics and Gerontology